Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Kleine-Levin syndrome is an ultra-rare neurological disorder with an estimated prevalence of approximately 1 to 2 cases per million people worldwide. While exact figures remain challenging to pinpoint, the condition predominantly affects adolescent males and typically follows a relapsing-remitting course that often resolves after several years. What is the estimated prevalence of Kleine-Levin syndrome? Kleine-Levin syndrome is classified as an ultra-rare condition.
TL;DR: Kleine-Levin syndrome is an ultra-rare neurological disorder with an estimated prevalence of approximately 1 to 2 cases per million people worldwide. While exact figures remain challenging to pinpoint, the condition predominantly affects adolescent males and typically follows a relapsing-remitting course that often resolves after several years.
Kleine-Levin syndrome is classified as an ultra-rare condition. Because of its rarity and the episodic nature of its symptoms, obtaining precise epidemiological data is difficult. Current estimates from the NIH Genetic and Rare Diseases Information Center (GARD) suggest a prevalence of approximately 1 to 2 per million individuals. However, researchers emphasize that this is likely an underestimate; Kleine-Levin syndrome is frequently misdiagnosed as psychiatric illness or other sleep disorders, meaning many cases remain unidentified in the general population.
The demographic profile of Kleine-Levin syndrome shows distinct patterns regarding age and sex. Clinical data consistently indicates the following trends:
There is currently no robust evidence to suggest that Kleine-Levin syndrome is linked to specific geographic regions, ethnicities, or socioeconomic backgrounds. It appears to occur globally across diverse populations. The apparent clusters of cases reported in medical literature are often attributed to heightened awareness within specific academic medical centers rather than true environmental or genetic "hotspots."
The primary barrier to understanding the true prevalence of Kleine-Levin syndrome is the diagnostic delay. Because the hallmark symptoms—periodic hypersomnia, cognitive impairment, and behavioral changes—mimic conditions like bipolar disorder, depression, or narcolepsy, patients often undergo years of misdiagnosis. Furthermore, because the symptoms are episodic, a patient may be asymptomatic when they finally see a specialist, making clinical observation during an active episode difficult. The DiseaseMaps.org community provides a vital, complementary perspective; currently, 13 people with Kleine-Levin syndrome have joined our platform to share their diagnostic journeys, highlighting the isolation and confusion that often precede an accurate diagnosis.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.